MRPL13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62503344114384E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.66453525910038E-15 |
Normal-vs-Stage2 |
8.977300E-03 |
Normal-vs-Stage3 |
2.15879536469288E-11 |
Normal-vs-Stage4 |
3.56810003765418E-09 |
Stage1-vs-Stage2 |
1.504960E-01 |
Stage1-vs-Stage3 |
5.199400E-01 |
Stage1-vs-Stage4 |
9.097800E-01 |
Stage2-vs-Stage3 |
7.063800E-02 |
Stage2-vs-Stage4 |
2.121800E-01 |
Stage3-vs-Stage4 |
5.564400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.626032641866E-12 |
Normal-vs-AfricanAmerican |
4.68380889628861E-12 |
Normal-vs-Asian |
1.292600E-01 |
Caucasian-vs-AfricanAmerican |
1.702620E-01 |
Caucasian-vs-Asian |
9.415200E-01 |
AfricanAmerican-vs-Asian |
5.568800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
3.99289490360388E-11 |
Male-vs-Female |
1.367190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.35219946351128E-10 |
Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
Normal-vs-Age(61-80Yrs) |
3.35420580199752E-12 |
Normal-vs-Age(81-100Yrs) |
2.204000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.966200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.529500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.508100E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.447400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.686360E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.939200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.10800299227776E-11 |
Normal-vs-Grade 2 |
3.15802939354626E-12 |
Normal-vs-Grade 3 |
2.33146835171283E-15 |
Normal-vs-Grade 4 |
1.6565999683138E-09 |
Grade 1-vs-Grade 2 |
2.047400E-01 |
Grade 1-vs-Grade 3 |
5.275200E-01 |
Grade 1-vs-Grade 4 |
8.118000E-01 |
Grade 2-vs-Grade 3 |
4.566000E-01 |
Grade 2-vs-Grade 4 |
2.401400E-01 |
Grade 3-vs-Grade 4 |
4.873400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.50621745578883E-12 |
Normal-vs-ccB subtype |
4.14579481855526E-11 |
ccA subtype-vs-ccB subtype |
7.098800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.17339471472633E-11 |
Normal-vs-N1 |
2.23560000000012E-05 |
N0-vs-N1 |
7.581200E-01 |
|
|